T cells in health and disease

L Sun, Y Su, A Jiao, X Wang, B Zhang - Signal transduction and …, 2023 - nature.com
T cells are crucial for immune functions to maintain health and prevent disease. T cell
development occurs in a stepwise process in the thymus and mainly generates CD4+ and …

Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis

H Qayoom, S Sofi, MA Mir - Immunologic research, 2023 - Springer
The immune system plays a vital role in suppressing tumor cell progression. The tumor
microenvironment augmented with significant levels of tumor-infiltrating lymphocytes has …

The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells

J Li, Z Xiao, D Wang, L Jia, S Nie, X Zeng, W Hu - Molecular Cancer, 2023 - Springer
Recent advances in neoantigen research have accelerated the development of tumor
immunotherapies, including adoptive cell therapies (ACTs), cancer vaccines and antibody …

Harnessing the potential of hydrogels for advanced therapeutic applications: Current achievements and future directions

P Lu, D Ruan, M Huang, M Tian, K Zhu… - … and Targeted Therapy, 2024 - nature.com
The applications of hydrogels have expanded significantly due to their versatile, highly
tunable properties and breakthroughs in biomaterial technologies. In this review, we cover …

Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma

S Klobuch, TTP Seijkens, TN Schumacher… - Nature Reviews …, 2024 - nature.com
Immunotherapy with immune-checkpoint inhibitors (ICIs) and targeted therapy with BRAF
and MEK inhibitors have revolutionized the treatment of melanoma over the past decade …

Immune biomarkers in triple-negative breast cancer: improving the predictivity of current testing methods

FM Porta, E Sajjadi, K Venetis, C Frascarelli… - Journal of Personalized …, 2023 - mdpi.com
Triple-negative breast cancer (TNBC) poses a significant challenge in terms of prognosis
and disease recurrence. The limited treatment options and the development of resistance to …

Current trends of clinical trials involving CRISPR/Cas systems

S Zhang, Y Wang, D Mao, Y Wang, H Zhang… - Frontiers in …, 2023 - frontiersin.org
The CRISPR/Cas9 system is a powerful genome editing tool that has made enormous
impacts on next-generation molecular diagnostics and therapeutics, especially for genetic …

Cellular therapy for lung cancer: focusing on Chimeric Antigen Receptor T (CAR T) cells and Tumor-Infiltrating Lymphocyte (TIL) therapy

V Katiyar, J Chesney, G Kloecker - Cancers, 2023 - mdpi.com
Simple Summary Lung cancer is the leading cause of cancer related mortality and morbidity
in the United States and worldwide. The advent of Immunotherapy has significantly …

Applications of cell therapy in the treatment of virus-associated cancers

K Toner, CD McCann, CM Bollard - Nature Reviews Clinical Oncology, 2024 - nature.com
A diverse range of viruses have well-established roles as the primary driver of oncogenesis
in various haematological malignancies and solid tumours. Indeed, estimates suggest that …

Engineering challenges and opportunities in autologous cellular cancer immunotherapy

CR Foley, SL Swan, MA Swartz - The Journal of Immunology, 2024 - journals.aai.org
The use of a patient's own immune or tumor cells, manipulated ex vivo, enables Ag-or
patient-specific immunotherapy. Despite some clinical successes, there remain significant …